A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon.
about
Simian Immunodeficiency Virus Infection of ChimpanzeesOrigins of HIV and the AIDS pandemicThe molecular population genetics of HIV-1 group OPreclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replicationSusceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analysesOverview of HIV molecular epidemiology among people who inject drugs in Europe and Asia.Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient.Recombinant viruses and early global HIV-1 epidemicVariability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in FranceMutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1.Universal amplification, next-generation sequencing, and assembly of HIV-1 genomes.Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.Non-M variants of human immunodeficiency virus type 1.Going wild: lessons from naturally occurring T-lymphotropic lentivirusesReduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assaysRapid assay for simultaneous detection and differentiation of immunoglobulin G antibodies to human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2.Extent of antigenic diversity in the V3 region of the surface glycoprotein, gp120, of human immunodeficiency virus type 1 group M and consequences for serotypingAnalysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1.Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M.Construction and analysis of an infectious human Immunodeficiency virus type 1 subtype C molecular clone.An exonic splicing silencer downstream of the 3' splice site A2 is required for efficient human immunodeficiency virus type 1 replication.Divergent evolution in reverse transcriptase (RT) of HIV-1 group O and M lineages: impact on structure, fitness, and sensitivity to nonnucleoside RT inhibitors.Inhibition of human immunodeficiency virus type 1 isolates by the integrase inhibitor L-731,988, a diketo AcidMulticenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificityEvaluation of a new combined antigen and antibody human immunodeficiency virus screening assay, VIDAS HIV DUO Ultra.The effects of internal primer-template mismatches on RT-PCR: HIV-1 model studiesPausing of reverse transcriptase on retroviral RNA templates is influenced by secondary structures both 5' and 3' of the catalytic site.Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African originGenetic and phylogenetic evolution of HIV-1 in a low subtype heterogeneity epidemic: the Italian examplePersistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual.Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG.Heteroduplex mobility assay and phylogenetic analysis of V3 region sequences of human immunodeficiency virus type 1 isolates from Gulu, northern Uganda. The Italian-Ugandan Cooperation AIDS Program.Inter- and intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes.Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency virusesIncreased envelope spike density and stability are not required for the neutralization resistance of primary human immunodeficiency virusesFailure of a human immunodeficiency virus type 1 (HIV-1) subtype B-derived vaccine to prevent infection of chimpanzees by an HIV-1 subtype E strainGenetic diversity of simian immunodeficiency viruses from West African green monkeys: evidence of multiple genotypes within populations from the same geographical locale.Evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple.Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications.
P2860
Q22065437-5ADB97C9-32ED-41F3-BF4C-849C4FF7926DQ22242661-377F05AE-DA13-4615-8668-B042AC48C5D9Q24545695-70D9D249-D506-4E87-ABBE-1440C69E0194Q28378825-298A880D-5A68-4322-9C8C-286404759F15Q28379196-60660C6C-F277-4783-8CAC-2A55B2FC04D9Q30249677-6C8BBD6F-DAE8-42A2-AAC4-468BBC051F3AQ30322838-CCE0E07C-48C5-4B91-8797-B8743D341198Q30342738-DB66BCA4-9CC7-413D-8686-13F048994A93Q30417537-F10C2D6F-878B-4050-85CD-2C5BF9D3053AQ30420728-3222C128-F29E-4DFD-B98E-916193DF274EQ30421453-0CB9C28D-F4E2-43CD-9117-E5773713869EQ30423779-3462410D-F130-49C8-888D-79314490F44FQ30432689-8B29CC8C-65F9-4FD1-9D1D-5C03E8EAB258Q31066870-6F08B220-A0A3-40B6-AE9C-B4E25BBD4B79Q33675677-291D6C8D-DDAA-4F34-B49F-31C72F128382Q33686306-05021470-D8DC-409C-B3F5-87F7E310ECA6Q33782134-38264427-911C-4CB1-8CDB-F06727AB443CQ33785338-71D1923F-D6AD-4CB5-8B09-358AA8823185Q33809112-B79143CF-0E15-41E6-A430-BE23AB13D95FQ33851598-46CE15B9-052B-476D-89BE-1C1A1C710036Q33911993-3561779C-B2CE-4F6A-B5B8-7403EE0D5A0DQ34120878-5D0D2EAA-954A-4E71-ABD3-19297A31FF29Q34144064-683FD2D3-40B3-41C8-886E-D41C3B88DD4BQ34195573-0BC90AF1-C0F1-43F6-82FC-E3C872B5F86AQ34453624-5DA993D8-CCEF-4350-A8F9-D21EAA762BE8Q34625250-C03ECA12-8E87-4866-A785-CF73AC7CCE77Q34671582-4C5E1E8F-6036-4403-A3EB-8498BD156D90Q35829520-632E4CD9-384C-4291-8271-1DA6014D7209Q35843775-2A845C0A-5BA8-40F7-B85D-F300B4096DD2Q35846005-85781307-EEEE-4D79-BC58-176362D319F5Q35849408-C271F623-B57B-4B97-A1D5-96380013DFC9Q35852493-54F1138B-A332-4642-BE9D-20F73639EC9AQ35853750-A23B4D1A-17A2-4CDF-88DB-51EE35B1275AQ35863198-9F2F618C-B0C9-4D0C-A4D8-FC64270C83BFQ35868205-2CF3B34D-A63D-4C75-902A-BC4AC894D8B3Q35872988-A1075277-CB32-4C46-960B-859F20CFCE05Q35874853-CB14FD21-C467-4D9A-94E7-038367764343Q35880196-2357A4D6-B70A-403B-9D0C-A82CEE63BB1FQ35905947-40F854E4-8106-4F0B-9EE0-3F9AE433BCBDQ36099119-1B598F61-7760-4C16-B8BA-232D93EA780C
P2860
A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon.
@ast
A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon.
@en
type
label
A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon.
@ast
A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon.
@en
prefLabel
A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon.
@ast
A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon.
@en
P2093
P2860
P1433
P1476
A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon.
@en
P2093
Gürtler LG
von Brunn A
P2860
P304
P407
P577
1994-03-01T00:00:00Z